75N93021C00009

GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY

National Institutes of Health · United States

This contract has been awarded. Browse open opportunities

View Source

Time Left to Bid

Awarded

AwardedOtherFederal

Basic information

Reference number: 75N93021C00009
Issuing organization: National Institutes of Health · Find award history →
Government level: Federal
Solicitation type: Other
Title: GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY
Source: USASpending (Federal)
Source ID: usa-75N93021C00009

Details

Location: United States

Description

GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY Awarded to: XEQUEL BIO, INC. Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT

Dates

Publication: 2021/03/16 12:00:00 AM UTC
Closing date: 2025/02/28 12:00:00 AM UTC

Estimated value

$6.6M USD

Classification

Normalized category

Other

Source: USASpending (Federal)

Last updated 2026-09-02, 1:08:36 a.m.

Data refreshed every 2 hours